PUBLISHER: The Business Research Company | PRODUCT CODE: 1760520
PUBLISHER: The Business Research Company | PRODUCT CODE: 1760520
Diabetes care refers to the comprehensive management and treatment of diabetes mellitus, a chronic condition marked by elevated blood sugar levels. It includes a variety of medical, lifestyle, and technological interventions aimed at keeping blood glucose within a target range and preventing complications.
The primary product types in diabetes care include glucose monitoring devices, insulin pumps, and other related products. Glucose monitoring devices are medical tools designed to measure and track blood glucose levels, primarily for individuals with diabetes. The different types of diabetes include type 1 diabetes, type 2 diabetes, and other forms, with these products being used by various end users, including hospitals and clinics, home care settings, ambulatory care centers, and others.
The diabetes care market research report is one of a series of new reports from The Business Research Company that provides diabetes care market statistics, including the diabetes care industry's global market size, regional shares, competitors with the diabetes care market share, detailed diabetes care market segments, market trends and opportunities, and any further data you may need to thrive in the diabetes care market. This diabetes care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The diabetes care market size has grown strongly in recent years. It will grow from $26.79 billion in 2024 to $29.25 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth during the historic period can be attributed to rising obesity rates, increased demand for continuous monitoring devices, growing investment in diabetes research and development, and a rising demand for personalized diabetes care.
The diabetes care market size is expected to see strong growth in the next few years. It will grow to $41.21 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. Growth during the forecast period is expected to be driven by the increasing prevalence of diabetes, an expanding geriatric population, heightened awareness of diabetes management, and improved healthcare access in developing regions. Key trends anticipated in the forecast period include technological advancements in diabetes monitoring, the integration of artificial intelligence (AI) in diabetes care, improvements in insulin delivery systems, and the development of smart insulin devices.
The rising prevalence of obesity is anticipated to drive the expansion of the diabetes care market in the coming years. Obesity rates refer to the proportion of individuals within a population who have a body mass index (BMI) of 30 or above, indicating obesity. The growth in obesity is largely due to increased dependence on sedentary lifestyles and the widespread consumption of highly processed, calorie-dense foods that offer minimal nutritional value, leading to an imbalance between caloric intake and physical activity. Diabetes care is essential in addressing obesity-related health challenges by promoting better lifestyle habits, enhancing glucose regulation, and supporting weight management through advanced treatment options like insulin therapy and continuous glucose monitoring (CGM) technologies. For instance, in March 2024, the World Health Organization, an intergovernmental body based in Switzerland, reported that in 2022, 390 million adults were underweight, while 2.5 billion were overweight, including 890 million classified as obese. As a result, increasing obesity levels are fueling demand within the diabetes care market.
Leading companies in the diabetes care industry are innovating with new technologies, such as automated insulin delivery (AID) systems, to enhance glucose control by seamlessly integrating continuous glucose monitoring devices with insulin pumps for real-time insulin adjustments. AID systems combine CGMs with insulin pumps to automatically manage insulin levels based on current glucose readings, helping patients maintain more consistent blood sugar control. For example, in February 2024, Tandem Diabetes Care Inc., a U.S.-based medical device company focused on diabetes treatment, launched the Tandem Mobi-an ultra-compact, durable automated insulin delivery system. This discreet, tubed insulin pump can be fully operated via a smartphone app, eliminating the need for a traditional controller. The device is waterproof, rechargeable, and integrates with Dexcom's CGM system, utilizing Tandem's established Control-IQ technology to automate insulin dosing.
In January 2023, Tandem Diabetes Care Inc. acquired AMF Medical SA for an undisclosed amount. This acquisition is aimed at accelerating the development and commercialization of advanced patch pump technology, broadening Tandem's diabetes care offerings, and reaching a wider patient base. AMF Medical SA is a Switzerland-based company specializing in innovative insulin delivery solutions for diabetes management.
Major players in the diabetes care market are F. Hoffmann-La Roche Ltd., Sanofi S.A., Abbott Laboratories, Medtronic plc, Eli Lilly and Company, Novo Nordisk A/S, Boehringer Ingelheim Pharmaceuticals Inc., Terumo Corporation, Dexcom Inc., Dr. Reddy's Laboratories Limited, SD Biosensor Inc., Insulet Corporation, Tandem Diabetes Care Inc., LifeScan Inc., Ypsomed AG, Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, Bionime Corporation, Arkray Inc., ACON Laboratories Inc., ViCentra B.V., Microtech Medical Ltd., Sinocare Inc., MicroGene Diagnostic Systems Pvt. Ltd.
North America was the largest region in the diabetes care market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in diabetes care report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the diabetes care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The diabetes care market consists of revenues earned by entities by providing services such as insulin therapy and medication management, nutrition and diet planning, lifestyle modification support, and telemedicine and remote monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The diabetes care market also consists of sales of products including dietary and nutritional products, medication delivery devices, and digital and software solutions. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Diabetes Care Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on diabetes care market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for diabetes care ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The diabetes care market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Subsegments